STRONGBRIDGE BIOPHARMA plc Long-Term Debt, Maturity, Year Five
STRONGBRIDGE BIOPHARMA plc had Long-Term Debt, Maturity, Year Five of $1.39 million as of 2020-06-30, per its 10-Q filed 2020-08-04.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive · last filed 2020-08-04
- 2020-06-30: Long-Term Debt, Maturity, Year Five $1.39M.
- 2018-09-30: Long-Term Debt, Maturity, Year Five $35.32M.
- 2018-06-30: Long-Term Debt, Maturity, Year Five $34.96M.
- 2018-03-31: Long-Term Debt, Maturity, Year Five $34.61M.
| Period end | Long-Term Debt, Maturity, Year Five |
|---|---|
| 2020-06-30 | $1.39M 10-Q · filed 2020-08-04 |
| 2018-09-30 | $35.32M 10-Q · filed 2018-10-31 |
| 2018-06-30 | $34.96M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $34.61M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $13.67M 10-K · filed 2018-03-12 |
| 2017-09-30 | $13.53M 6-K · filed 2017-11-14 |